trending Market Intelligence /marketintelligence/en/news-insights/trending/efbcu1dzFubSiXaCPC7jhg2 content esgSubNav
In This List

Castlight Health maintains FY'17 outlook

Blog

Fintech Intelligence Digital Newsletter: May 2021

Street Talk – Episode 76: Record pace of fintech M&A, funding in Q1'21 has legs

Fintech Intelligence Digital Newsletter: April 2021

Podcast

Street Talk | Episode 76: Record pace of fintech M&A, funding in Q1'21 has legs


Castlight Health maintains FY'17 outlook

Castlight Health Inc. continues to expect to record a non-GAAP net loss per share for the full year of 24 cents to 28 cents.

The S&P Capital IQ consensus normalized estimate for the year calls for a loss of 26 cents per share.

The company also maintained its guidance for a non-GAAP operating loss of $31 million to $35 million and GAAP revenue of $132 million to $136 million.

For the second quarter, Castlight Health reported a net loss of $13.7 million, or 11 cents per share, compared with a net loss of $16.7 million, or 17 cents per share, in the year-ago period.

The second-quarter non-GAAP net loss was $9.8 million, or 7 cents per share, compared with a loss of $5.3 million, or 5 cents per share, in the second quarter of 2016.

The S&P Capital IQ consensus normalized estimate for the quarter called for a loss of 9 cents per share